Crizotinib Induces Autophagy Through Inhibition of the STAT3 Pathway in Multiple Lung Cancer Cell Lines

Oncotarget - United States
doi 10.18632/oncotarget.5592
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Cyclosporine a Sensitizes Lung Cancer Cells to Crizotinib Through Inhibition of the Ca2+/Calcineurin/Erk Pathway

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Synthetic Lethal Interaction of CDK Inhibition and Autophagy Inhibition in Human Solid Cancer Cell Lines

Oncology Reports
MedicineCancer ResearchOncology
2017English

Low Frequency Magnetic Fields Induce Autophagy-Associated Cell Death in Lung Cancer Through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway

Scientific Reports
Multidisciplinary
2017English

AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway

Oncology Letters
Cancer ResearchOncology
2019English

Curcumin Induces the Apoptosis of Non-Small Cell Lung Cancer Cells Through a Calcium Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2015English

Bruceine D Induces Lung Cancer Cell Apoptosis and Autophagy via the ROS/MAPK Signaling Pathway in Vitro and in Vivo

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Resveratrol Induces Cell Cycle Arrest and Apoptosis in Malignant NK Cells via JAK2/STAT3 Pathway Inhibition

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy